People who base their health choices on what they found on the internet instead of talking to their doctors have long since been regarded with a generous amount of disdain. However, a new study suggests that using web-based counseling is actually just as effective at lowering blood pressure as taking actual medication.
The study was presented during the 66th Annual Scientific Session and Expo, which was held in Washington, D.C., The Washington Post reports. It looked at the cases of patients who enrolled in the website Heart and Stroke Association of Canada, where over 264 people diagnosed with high blood pressure and with an average age of 56 years old were tracked.
The groups were divided based on Web-based lifestyle counseling and Web-based control intervention, both of which involved different approaches to addressing systolic blood pressure. It would seem that the former method yielded better results than the latter, but both systems did accomplish the goal of reducing mmHg levels in the patients.
Robert P. Nolan from the Peter Munk Cardiac Center at the University Health Network is the lead author of the study and he calls web-based counseling e-Counseling. He confirmed that this method had similar results compared to having the patients take drugs in order to control their blood pressure.
“The electronic counseling (e-Counseling) intervention had an effect similar to that of adding an additional blood-pressure-lowering medication,” Prof. Nolan said.
As to what this so-called e-Counseling even involves, patients are given a variety of resources in order to help them cope with their health condition. These include interactive online content, as well as a few video and audio resources, MedicalXpress reports. Based on the results that the researchers got from the study, it would seem that the more engaging content yielded the best improvements in lowering blood pressure among the patients.


FDA Names Tracy Beth Høeg as Acting CDER Director After Richard Pazdur Announces Retirement
ByteDance Finalizes Majority U.S.-Owned TikTok Joint Venture to Avert American Ban
U.S. Lawmakers Demand Scrutiny of TikTok-ByteDance Deal Amid National Security Concerns
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
Morgan Stanley Flags High Volatility Ahead for Tesla Stock on Robotaxi and AI Updates
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Elon Musk Seeks $134 Billion in Lawsuit Against OpenAI and Microsoft Over Alleged Wrongful Gains
Nintendo Stock Jumps as Switch 2 Becomes Best-Selling Console in the U.S. in 2025
Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
Samsung Set to Begin HBM4 Production for Nvidia and AMD
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing
Trump Backs Review of U.S. Childhood Vaccine Schedule After Hepatitis B Policy Change
Memory Chip Shortage Drives Higher Gadget Prices and Weakens Global Tech Demand 



